MedTech Terms
    The authoritative reference
    All terms
    Market SegmentsStrategic Landscape

    Drug Delivery Devices

    Devices that administer therapeutics - autoinjectors, pumps, inhalers.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Drug delivery devices include prefilled syringes, autoinjectors (e.g., GLP-1 pens), wearable injectors (West, Insulet), implantable pumps, and inhalation devices. Often regulated as combination products via CDER-led review with CDRH consult.
    What the regulation says
    Drug delivery devices, when combined with a drug, are typically regulated as combination products by health authorities like the FDA. The FDA outlines requirements for combination products in 21 CFR Part 3, and often involves a lead center, such as the Center for Drug Evaluation and Research (CDER) with consultation from the Center for Devices and Radiological Health (CDRH), to ensure both the drug and device aspects meet applicable regulations. The EU MDR (Regulation (EU) 2017/745) also addresses devices incorporating a medicinal substance, requiring consultation with a medicines authority on the safety, quality, and usefulness of the substance.

    What this means in practice

    GLP-1 demand has driven massive autoinjector and prefilled-syringe capacity expansion. Combination product CMC and human factors are gating items.

    Examples

    • A pre-filled syringe containing a vaccine is a drug delivery device regulated as a combination product, with the syringe being the device component and the vaccine being the drug component.
    • An autoinjector designed to deliver epinephrine in an emergency is a combination product; the device facilitates rapid drug administration, and the drug provides the therapeutic effect.
    • An insulin pump, when pre-filled with insulin, functions as a drug delivery device and is regulated as a combination product due to the integrated drug and device components.
    Common pitfalls
    • •Assuming that drug delivery devices are solely regulated as medical devices overlooks the critical aspect of combination product regulation.
    • •Neglecting to consider the human factors engineering requirements specific to drug delivery devices can lead to usability issues and regulatory non-compliance.
    • •Failing to adequately address the Chemistry, Manufacturing, and Controls (CMC) aspects for the drug component of a combination product can cause significant regulatory delays.
    • •Overlooking post-market surveillance requirements that apply to both the device and drug components of a combination product can result in regulatory sanctions.

    Frequently asked questions

    A combination product in this context is a product comprised of two or more regulated components, such as a drug and a device, that are combined to achieve a specific therapeutic effect. For drug delivery devices, this typically means the device is pre-filled or co-packaged with a drug.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    FDA·1MedTech Dive·1AdvaMed·1
    1. 1
      FDA combination products
      Verified
      FDAfda.gov
    2. 2
      MedTech Dive
      Verified
      MedTech Divemedtechdive.com
    3. 3
      AdvaMed - Industry Reports
      Verified
      AdvaMedadvamed.org

    Inline markers like [1] jump to the matching reference above.